Kewajiban Lancar Perubahan Tanggal
Amgen USD 24.96B 534M 2026-03
Bio Techne USD 140.43M 4.12M 2025-12
Cassava Sciences USD 43.83M 4.21M 2025-12
Cytokinetics USD 199.18M 3.27M 2026-03
Esperion Therapeutics USD 300.81M 58.22M 2025-12
Exelixis USD 405.64M 31.86M 2025-12
Genmab DKK 1.43B 686M 2025-12
Geron USD 113.82M 26.11M 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
Incyte USD 1.49B 25.52M 2026-03
MacroGenics USD 43.11M 1.36M 2025-12
Novartis USD 31.37B 4.1B 2026-03
Novavax USD 342.46M 117.49M 2026-03